APAA Celebrates One Year of President Trump’s 50% Section 232 Aluminum Tariff and Historic Investments in U.S. Manufacturing

1. 
   Home
2. 
   News
3. 
   PR Newswire
4. 
   

   APAA Celebrates One Year of President Trump’s 50% Section 232 Aluminum Tariff and Historic Investments in U.S. Manufacturing

APAA Celebrates One Year of President Trump’s 50% Section 232 Aluminum Tariff and Historic Investments in U.S. Manufacturing

APAA Celebrates One Year of President Trump’s 50% Section 232 Aluminum Tariff and Historic Investments in U.S. Manufacturing

PR Newswire

WASHINGTON, June 5, 2026

WASHINGTON, June 5, 2026 /PRNewswire/ — Today, the American Primary Aluminum Association celebrates the one-year anniversary of President Trump’s 50% Section 232 aluminum tariff. This tariff is revolutionizing domestic manufacturing production, strengthening supply chains, creating thousands of new jobs, generating billions of dollars in US investment, and fortifying our national security. President Trump strengthened the Section 232 aluminum tariff to combat unfair trade practices and persistent cheating by foreign governments, delivering unprecedented wins for American workers in the aluminum industry:

• Emirates Global Aluminum and Century Aluminum plan to build the first new US smelter in nearly 50 years, a more than $4 billion investment that will more than double U.S. production capacity and create over 5,000 jobs in Oklahoma.
• Century Aluminum restored their Mt. Holly smelter to full production capacity, creating over 100 U.S. aluminum jobs in South Carolina and increasing U.S. aluminum production by over 10%.
• Novelis is investing $5 billion into a new aluminum rolling mill, creating up to 1,000 jobs in Alabama.
• Aluminum Dynamics officially launched commercial production at a new, state-of-the-art recycled aluminum flat rolled mill in Mississippi, a $2.5 billion investment that has created over 700 jobs.

“One year ago today, President Trump took decisive action to stand up for American workers by launching a new Golden Age for domestic aluminum manufacturing,” remarked APAA President Mark Duffy. “The results speak for themselves: the aluminum industry is delivering billions of dollars in U.S. investment and creating thousands of American aluminum jobs, and it’s all due to President Trump’s 50% Section 232 tariff, with no exemptions or exclusions.”

About the American Primary Aluminum Association:

The American Primary Aluminum Association advances the interests of America’s primary aluminum industry and its workers through the Aluminum Now campaign. APAA is registered and incorporated in Washington, DC and operates as a non-profit trade association. For more, please visit: www.aluminumnow.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/apaa-celebrates-one-year-of-president-trumps-50-section-232-aluminum-tariff-and-historic-investments-in-us-manufacturing-302792742.html

SOURCE American Primary Aluminum Association

The articles, information, and content displayed on this webpage may
include materials prepared and provided by third parties. Such
third-party content is offered for informational purposes only and
is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the
accuracy, completeness, timeliness, or reliability of any third-party
content displayed on this site. The views and opinions expressed in
third-party content are those of the respective authors and do not
necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays
in this content, nor for any actions taken in reliance thereon.
Users are advised to exercise their own judgment and seek independent
financial advice before making any decisions based on such content.
The third-party providers of this content are not affiliated with
Morningstar, and their inclusion on this site does not imply any
form of partnership, agency, or endorsement.

Source link

PODCAST | Could Trade Deal Uncertainty Slow America’s Manufacturing Comeback?

As manufacturers weigh new investments in U.S. capacity, automation and reshoring, trade certainty is becoming a central factor in where companies source components and place final assembly.

The U.S.-Mexico-Canada Agreement, or USMCA, is heading toward its first formal review on July 1. The outcome could affect supply chains, production planning and long-term investment decisions across North America.

Industry insiders fear that the Trump administration’s concerns that Canada and Mexico are not treating the United States fairly in certain areas could complicate the renewal process.

“We’ve got to stay in this relationship and work on it, not be threatening it with a divorce,” says Patrick Lozada, Senior Director of Global Policy at the National Electrical Manufacturers Association.

While acknowledging there are legitimate issues that need to be addressed during the upcoming USMCA review, he argues that manufacturers still need the long-term certainty and integrated North American supply chains that the agreement provides. 

The agreement lays down rules for how components qualify to move across borders duty-free. Lozada says that structure has helped manufacturers deepen investments across North America.

NEMA is urging the three governments to renew the agreement for another 16 years, while still using existing mechanisms to resolve disputes and update portions of the agreement.

Looking for quick answers on assembly and manufacturing topics?


Try Ask ASM, our new smart AI search tool.













Ask ASM →

“A long-term renewal would not mean a static agreement,” Lozada says. “But what it would do is provide a sense of direction and certainty for manufacturers.”

That certainty is especially important for electrical manufacturers because the sector relies on a deeply integrated North American value chain.

“USMCA has allowed us to link design, engineering, manufacturing, assembly, testing, certification and services between all three countries,” Lozada says.

He says that integration has also helped the industry reduce reliance on China.

“Since 2018, China’s market share of electrical industry imports to the United States has decreased by 49%,” Lozada says.

Electrical manufacturing is also becoming increasingly important as AI, data centers, automation and advanced manufacturing expand.

“Electrical components comprise approximately one-third of the total spend to build a typical AI data center,” Lozada says. They also represent about 10% of the total spend for a new U.S. manufacturing facility.

NEMA projects U.S. electricity demand will increase by 55% by 2050, with data centers as a major driver. Lozada says AI data centers alone are expected to increase their share of energy demand by 300% over the next 10 years.

“We’ve got to have a grid that keeps pace with the incredible change in demand,” Lozada says.

Trade uncertainty, however, can complicate those investments. Lozada says changing tariff levels are especially difficult for manufacturers planning long-term production.

“If one day you’re paying 0% under a trade agreement, and then the next day you’re facing a 25% tax, and then the next day you’re facing a 10% tax, that is kryptonite for long-term certainty for manufacturers,” he says.

Lozada says NEMA also sees the USMCA review as an opportunity to resolve standards and regulatory issues, especially in Mexico. He says Mexico has not updated its electrical code since 2012, leaving it three editions behind the U.S. and Canada.

“Nobody supports an old electrical code,” Lozada says. “Nobody should support having standards that are out of date.”

If USMCA remains in limbo after the review, Lozada expects manufacturers and investors may interpret continued negotiations as manageable in the near term, but insufficient for long-term planning.

Certainty, Lozada says, is necessary for manufacturers considering new production capacity, new lines or new facilities.

“Manufacturers want to see certainty around what they’re going to pay,” Lozada says. “What they’re going to pay in terms of tariffs and taxes on their inputs, and then what markets they’re going to be able to access.”

NEMA is also advocating for a tariff incentive framework that would provide tariff relief or rebates for companies investing in U.S. manufacturing.

“If you’re investing in America, you’re bringing manufacturing back home, let’s get a discount off of those tariffs,” Lozada says.

According to Lozada, the framework could help advance U.S. manufacturing investment while managing costs for manufacturers and consumers.

Source link

Beyond modules: why US solar’s future depends on upstream manufacturing scale-up

Beyond modules: why US solar’s future depends on upstream manufacturing scale-up – PV Tech

Skip to content

Source link

Trump Revamps Metals Tariffs to Give Relief to US Manufacturing and Agriculture

President Donald Trump signed a proclamation on Monday (June 1) lowering duties on agricultural and industrial machinery while expanding the tariff net to cover new industrial components.

The adjustments, which take effect on June 8, reduce tariffs on agricultural equipment and residential HVAC systems to 15 percent from 25 percent.

The order also extends the 15 percent tariff category to mobile industrial equipment, such as bulldozers and forklifts, provided the goods are imported from nations with active US trade agreements.

“Among other things, the Secretary (of Commerce) has informed me that recent circumstances have affected and are affecting domestic industries that use agricultural equipment, industrial equipment and machinery, and other related products,” Trump said in the proclamation.

He added that the temporary changes “appropriately accounts for these products’ roles in productive economic activity in the United States.”

The administration also lowered the threshold for foreign manufacturers to qualify for preferential duty rates. Under the new rules, imported capital equipment can qualify for a 10 percent tariff rate if it contains at least 85 percent US melted and poured or smelted and cast steel or aluminum by weight.

Previously, foreign products faced a 15 percent rate and required a 95 percent domestic metal composition.

While relaxing rules for downstream machinery users, the order expands the scope of the tariff regime. The proclamation adds steel racks and aluminum lithographic plates to the list of derivative products subject to a 25 percent tariff rate.

The changes modify a sequence of aggressive trade penalties implemented since Trump renewed the Section 232 tariffs in April 2025, which included hiking baseline steel and aluminum import tariffs to 50 percent in June 2025.

The conflict in the Middle East has disrupted international steel shipments into the US, driving up domestic material costs. However, manufacturers report that domestic buyers are absorbing the premium to secure guaranteed delivery schedules.

The restrictive trade policies have reshaped North American supply chains since the 50 percent baseline tariffs were enacted one year ago. For instance, Canadian manufacturers, who supply a significant volume of the continent’s agricultural machinery, have faced constrained access to the US market.

Copper joins the threshold

The specific adjustment extends to copper products, as the administration seeks to incentivize the use of US-mined and processed critical minerals.

In a fact sheet released last April, the White House explicitly cited domestic capacity expansions by Highland Copper Company Inc. (TSXV:HI,OTCQB:HDRSF) Ivanhoe Electric (NYSE AMERICAN:IE,TSX:IE), Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO), and Wieland as evidence that its tariff regime is successfully redirecting capital into the domestic supply chain.

“This White House statement is an important acknowledgement of Highland’s Copperwood project. It also reflects our visibility to the administration and key US federal agencies,” CEO Barry O’Shea said in a company press release last month.

The administration stated these expansions prove that Section 232 protections ensure domestic producers can compete against lower-priced foreign imports.

It further maintained that the protective measures are successfully redirecting industrial investment, noting that US manufacturing expanded in May 2026 at its fastest pace in four years.

For instance, domestic crude steelmaking capacity is projected to grow by over 4 million tons over the next two years, with new facility investments underway in West Virginia, Arkansas, and South Carolina.

Additionally, Century Aluminum (NASDAQ:CENX) and Emirates Global Aluminum earlier this year announced a joint venture to construct a new aluminum smelter in Oklahoma.

Don’t forget to follow us @INN_Resource for real-time news updates!

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Source link

Sharp, stronger improvement in US manufacturing conditions: May PMI

S&P Global purchasing managers’ index (PMI) data for May this year signalled a sharp and stronger improvement in US manufacturing conditions amid the sharpest upturn in production since April 2022.

New orders increased markedly again, but growth in both output and sales was in part driven by stock building as firms sought to protect themselves from supply chain disruption and steeply rising prices, caused primarily by the war in the Middle East, which remained a notable headwind for the sector.

Manufacturing input costs in the country rose at a rate unmatched in nearly four years, whilst supplier delivery times deteriorated to the greatest extent since August 2022, a release from S&P Global said.

S&P Global PMI data for May signalled a sharp and stronger improvement in US manufacturing conditions amid the sharpest upturn in production since April 2022.
New orders rose markedly again, manufacturing input costs rose at a rate unmatched in four years, confidence in the outlook softened since April and exports were a notable source of demand weakness, falling overall for the eleventh month in a row.

Confidence in the outlook also softened since April, though remained sufficiently positive to help explain a further rise in employment.

The seasonally-adjusted PMI for the country recorded 55.1 in May, up from 54.5 in the previous month, signalling a stronger rate of expansion in the manufacturing economy.

The latest index reading was the highest since May 2022 and has now posted above the critical 50 no-change mark for 10 successive months. The upturn in the PMI emanated in part from a stronger rise in production, with growth reaching the highest in just over four years, S&P Global noted.

Output growth was notably faster than new orders and rose sufficiently strongly for firms to add to their stocks of finished goods for the second successive month and at the quickest pace since last November. Overall new orders increased at a sharp pace, but softer than in April and largely driven by client efforts to build stock given expectations of further price rises and supply delays.

Exports were a notable source of demand weakness, falling overall for the eleventh month in a row.

Geopolitical instability and tariffs were reported to have weighed on foreign sales in the latest survey period. Rising raw material prices, particularly for fuel and oil-related products, pushed up input prices during May.

Input cost inflation increased from April to the highest since July 2022. Manufacturers’ own charges rose to the greatest extent since September 2022 as they sought to pass through their own higher expenses to clients wherever possible.

Purchasing activity rose solidly since April and was often linked to higher production requirements and efforts to mitigate against further price increases and supply chain disruption.

Subsequently, input stocks rose for the second successive month, with growth picking up to its highest since May 2025. That was despite difficulties sourcing and receiving inputs amid supply constraints and shipment delays from vendors. Overall, latest data revealed the most severe deterioration in vendor delivery times since August 2022.

May survey data signaled a renewed increase in staffing numbers. Although the rate of job creation was only modest, it was the best for five months.

A positive outlook in part helped encourage additional hiring, with manufacturers generally anticipating an increase in sales and output over the coming 12 months.

Fibre2Fashion News Desk (DS)

Source link

Indiana manufacturing push and acquisition drive keep focus on

Eli Lilly & Co. shares on the NYSE traded above USD 1,060 on 06/03/2026 as the United States-based pharma group steps up a multibillion-dollar manufacturing expansion in Indiana and signals a more aggressive acquisition strategy for its drug pipeline.

Eli Lilly & Co. shares remain in focus on the New York Stock Exchange as investors digest the latest signals on the United States company’s capital deployment, combining large-scale manufacturing investments in Indiana with an expanded acquisition strategy to bolster its portfolio of innovative medicines. The stock traded around USD 1,064 on 06/03/2026 on the NYSE under the ticker LLY, according to data cited by GuruFocus as of 06/03/2026, keeping the United States blue chip firmly among the largest healthcare names by market capitalization.

The Indianapolis-based group has been pushing ahead with a sizable expansion of its domestic production base. According to an article published by Manufacturing in Focus on 06/2026, Eli Lilly is topping out its Indiana investment by allocating an additional USD 4.5 billion to its manufacturing footprint in the state, building on earlier commitments to facilities including its LEAP Research and Innovation District near Indianapolis. The report highlights that the expansion is intended to support growing demand for the company’s diabetes and obesity treatments and other biologic therapies, while anchoring high-value pharmaceutical manufacturing in the United States.

Parallel to this capital expenditure program, management has also been signaling a more assertive approach to business development. On 06/03/2026, GuruFocus reported that Eli Lilly’s oncology dealmaker Jacob Van Naarden is leading a significant ramp-up in acquisitions, with more than USD 10 billion of deals already announced in 2026 to acquire or partner with smaller biotech innovators. The article notes that across eight transactions this year, the company has committed over USD 10 billion upfront and potentially up to USD 25 billion when including milestone payments, as it targets cutting-edge assets in oncology and other high-growth therapeutic areas.

The same GuruFocus analysis calculates a proprietary GF Value of USD 1,388.64 per share for Eli Lilly as of 06/03/2026 versus a contemporaneous share price of about USD 1,064.15, implying the stock was trading at roughly a 23.4 percent discount to that intrinsic value estimate. While this is not a market consensus, it illustrates how one valuation framework interprets the company’s growth trajectory, pipeline prospects, and balance sheet strength at the current trading level on the NYSE. For German investors accessing the stock via off-exchange platforms, Eli Lilly is also tradeable on venues such as Tradegate in euros, although liquidity and reference pricing remain centered on the US listing.

Interest from institutional investors continues to underpin trading in the United States. According to a MarketBeat filing summary dated 06/03/2026, Westpac Banking Corp increased its position in Eli Lilly by 39.5 percent in the fourth quarter, purchasing 4,030 additional shares and bringing its total holdings to 14,235 shares. The disclosure underscores how large global asset managers are still adding exposure to the group, with the same MarketBeat overview citing a consensus rating of “Moderate Buy” and an average price target of USD 1,227 among covering analysts as of the latest data. These figures provide a snapshot of how the sell side is framing upside and risk for the stock at current levels.

The combination of escalation in US-based manufacturing investment and heightened acquisition activity is central to how the market evaluates Eli Lilly’s growth case. Investors are paying close attention to whether the expanded Indiana production network will effectively support supply for high-demand medicines, and how quickly newly acquired pipeline assets can be integrated and advanced through clinical trials and regulatory review. With the company’s primary listing and regulatory reporting anchored in the United States, updates via NYSE trading data and SEC filings will remain key reference points for both domestic and international shareholders following the stock.

As of: 06/03/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Eli Lilly & Co.
• Sector/industry: Pharmaceuticals and biotechnology
• Headquarters/country: Indianapolis, United States
• Core markets: United States, Europe, key international pharmaceutical markets
• Key revenue drivers: Diabetes and obesity therapies, immunology and oncology drugs, other specialty pharmaceuticals
• Home exchange/listing venue: New York Stock Exchange (LLY)
• Trading currency: USD

Eli Lilly & Co.: core business model

Eli Lilly focuses on discovering, developing, and commercializing branded prescription medicines, with revenue concentrated in chronic disease areas such as diabetes, obesity, immunology, and oncology that can support long product lifecycles and premium pricing.

Eli Lilly & Co. in peer comparison

In the global large-cap pharmaceutical space, Eli Lilly is often assessed alongside peers such as Novo Nordisk, Pfizer, and Johnson & Johnson, which likewise operate diversified portfolios of patented therapies and vaccines. Novo Nordisk, for example, has also invested heavily in obesity and diabetes medicines and reached a market capitalization above USD 500 billion in early 2026 on the back of demand for GLP-1-based treatments, underlining the scale of the metabolic disease opportunity for sector leaders. Pfizer, by contrast, has been reallocating cash flows from its COVID-19 franchise into pipeline rebuilds and bolt-on acquisitions, while Johnson & Johnson maintains a more diversified business that includes medical devices and consumer health in addition to pharmaceuticals.

Compared with these peers, Eli Lilly’s current strategy of combining substantial US manufacturing commitments in Indiana with an enlarged acquisition budget exceeding USD 10 billion in 2026 places it toward the more aggressive end of the spectrum in terms of reinvesting cash into long-term growth initiatives. Investors monitoring the stock on the NYSE and in European trading are therefore weighing similar questions across the peer group: how quickly new metabolic and oncology products can be scaled, how effectively supply chains can keep pace with demand, and whether the balance between shareholder returns and reinvestment supports sustainable earnings growth.

Sentiment and reactions on Eli Lilly & Co.

The combination of expanded Indiana manufacturing investment and a more active acquisition pipeline has sparked ongoing discussion among market participants on social platforms about how these moves might influence Eli Lilly & Co.’s long-term earnings power and valuation.

YouTubeXTikTokInstagram

Conclusion

Eli Lilly & Co. remains a closely watched United States healthcare stock, with its NYSE-listed shares trading just above USD 1,060 on 06/03/2026 as the group deploys capital into an expanded Indiana manufacturing footprint and a stepped-up acquisition agenda. The latest reports on more than USD 10 billion of 2026 dealmaking and an additional USD 4.5 billion in state-side plant investment highlight the company’s decision to prioritize future capacity and pipeline breadth alongside ongoing shareholder returns.

For investors comparing Eli Lilly & Co. with global pharma peers such as Novo Nordisk, Pfizer, and Johnson & Johnson, the current strategy underscores a distinct emphasis on scaling high-demand metabolic and oncology therapies through both organic infrastructure builds and external innovation sourcing. How effectively these initiatives translate into sustained revenue and earnings growth over the medium term will remain central to how the stock is valued on the New York Stock Exchange and in secondary trading venues worldwide.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

en | US5324571083 | ELI LILLY & CO. | boerse | 69478848 | bgmi

Source link

GBP/USD Forecast: Strong US Manufacturing Data Lifts the US Dollar

Modified: Tuesday, 2 June 2026 22:01 BST

– Written by


David Woodsmith

STORY LINK GBP/USD Forecast: Strong US Manufacturing Data Lifts the US Dollar

The Pound US Dollar (GBP/USD) exchange rate fell on Monday as escalating tensions in the Middle East and stronger-than-expected US data lifted the safe-haven ‘Greenback’.

At the time of writing, GBP/USD was trading at $1.3421, down more than 0.2% on the day.

The safe-haven US Dollar (USD) strengthened on Monday as a deterioration in market sentiment drove investors towards safer assets.

The latest bout of risk aversion followed an exchange of strikes between the US and Iran over the weekend. Iran subsequently accused the US and Israel of breaching the ceasefire agreement and stated that it would withdraw from peace talks until Israel halted its attacks on Lebanon.

Meanwhile, the currency also drew support from upbeat US economic data. The latest ISM manufacturing PMI showed that factory activity accelerated more sharply than expected in May, with the index rising from 52.7 to 54, beating forecasts of 53.

Meanwhile, the increasingly risk-sensitive Pound (GBP) weakened against its safer peers as the market mood soured.

Sterling had initially edged higher in the morning after the UK’s latest manufacturing PMI showed activity climbing to a four-year high in May. The survey also reported rising input price inflation, which fuelled expectations for further Bank of England (BoE) interest rate hikes.

Save on Your GBP/USD Transfer

Get better rates and lower fees on your next international money transfer.
Compare TorFX with top UK banks in seconds and see how much you could save.

Compare the Best GBP/USD Rates »

While this may have helped to limit the Pound’s losses, domestic political uncertainty may have dented GBP. On Monday, the government published documents relating to the controversial appointment of Peter Mandelson as ambassador to the US, with the UK’s febrile political atmosphere potentially unnerving investors.

Near-Term GBP/USD Forecast: Could BoE Comments Boost Sterling?

Looking ahead, UK economic data is limited on Tuesday. However, BoE policymaker Megan Greene is due to speak in the afternoon. As Greene is considered one of the more hawkish members of the Monetary Policy Committee, Sterling could strengthen if she argues in favour of higher interest rates.

Tuesday will also see the publication of the latest US Job Openings and Labor Turnover Survey (JOLTS). The data is expected to show a marginal decline in job openings in April, which may have only a muted impact on the US Dollar. However, any surprises could spark sharper movement.

Elsewhere, developments in the Middle East could inject volatility into GBP/USD by influencing risk appetite. Hopes of peace may lift market sentiment and potentially support the Pound, while a fresh escalation in tensions would likely sour the mood and bolster the safe-haven US Dollar.

Like this piece? Please share with your friends and colleagues:

International Money Transfer? Ask our resident FX expert a money transfer question or try John’s new, free, no-obligation personal service! ,where he helps every step of the way,
ensuring you get the best exchange rates on your currency requirements.

TAGS: Pound Dollar Forecasts

Source link

U.S. Should Substantially Boost Support for Manufacturing USA Program, Issue National Industrial Manufacturing Strategy, Says New Report

To better compete globally, the United States should develop a comprehensive industrial strategy to align resources for manufacturing and maximize the national security and economic impacts of the Manufacturing USA program, a proven model that connects the key actors — small and large industry, engineering and science expertise, state and local government, and economic development stakeholders — needed to advance progress in manufacturing technology, says a new report by the National Academies of Sciences, Engineering, and Medicine. Nearly all leading competitor nations have detailed national manufacturing strategies that are aligned with their national economic strategies and view manufacturing as crucial to their growth and national security, the report says.

Strengthening the Manufacturing USA program — a public-private partnership coordinated through the National Institute of Standards and Technology comprising 17 institutes that specialize in different types of advanced manufacturing — is essential for bolstering U.S. competitiveness in the next decade, the report says. The network of institutes is a vital national asset that plays a central role in aligning innovation efforts across government, industry, and academia, connecting American businesses of all sizes with state-of-the-art technology and translating the latest breakthroughs into industrial practice.

However, the report says, the nation is missing a coordinated framework to align industry and government efforts, which has led to under-resourcing federal manufacturing programs, including Manufacturing USA, and a lack of investments to scale up production in proven areas.

As a result, U.S. manufacturing productivity — once a hallmark of the economy — has declined markedly in the past 15 years, the report says. China has been the world leader of manufacturing output since 2011, and currently holds around 35 percent of gross world manufacturing, compared to 12 percent in the U.S. The U.S. trade deficit in goods has also risen sharply, reaching a record $1.2 trillion in 2025, which includes a major deficit in advanced technologies such as aircraft, semiconductors, and robots.

“Even though the U.S. develops many manufacturing technologies, the nation continues to outsource most of its manufacturing and lags far behind other nations in production capacity,” said Theresa Kotanchek, chief executive officer of Evolved Analytics LLC and chair of the committee that wrote the report. “This presents risks to our supply chains, our economy, and our national security if we can’t access critical technologies when we need them most. Our report outlines actions to strengthen the Manufacturing USA program and U.S. advanced manufacturing so that we can grow the businesses and produce the technologies we need at home.”

The report calls on the National Economic Council, Office of Science and Technology Policy, the departments of Commerce, Defense, and Energy, and other agencies to develop within the next two years an industrial strategy — in concert with the National Security Strategy — that integrates technology development, scale-up financing, and leadership in standards, trade, and workforce development so that resources are aligned for a more robust U.S. advanced manufacturing posture.

Informed by tools available in leading advanced manufacturing countries, Congress and federal agencies should set policy to create new federal manufacturing and financing mechanisms that include long-term investment vehicles such as patient-capital funds, a sovereign wealth fund with a strategic focus on manufacturing, and intellectual-property backed lending financing. In addition, Congress should create a globally competitive research and development tax credit for manufacturing processes and technologies, as well as explore expanding other tax reforms that support manufacturing.

Congress should provide sustained, dedicated funding above current appropriations by 2030 to establish business development offices at each Manufacturing USA institute, the report says. These offices would support commercialization, scale-up, and regional ecosystem integration, particularly for entrepreneurs and small- and medium-sized manufacturers (SSMs) working in coordination with regional economic development organizations and federal manufacturing programs.

Technology transfer is central to the Manufacturing USA mission. Institutes need to support two small firm extremes, both of which often lack the capital and resources to scale up — at one end, small, innovative entrepreneurs with good ideas to develop nascent technologies and at the other, SSMs that need to implement proven technologies. Additionally, large, multinational corporations that are institute members want to accelerate technology transfer to reduce their risks in scaling up investments. The report recommends establishing dedicated in-house technology transfer teams to help bridge the innovation “valley of death” between early-stage research and full-scale production.

Supporting robust pathways to careers in advanced manufacturing is necessary to cultivate a skilled workforce that can operate, maintain, and improve complex emerging manufacturing technologies in areas such as robotics, data analysis, digital production, and new materials. Yet, attracting and retaining talent remains a challenge, the report says.

“Collaboration across institutions and work sectors, to align student outcomes with industry needs, is necessary for the U.S. to become a leader in advanced manufacturing,” said National Academy of Engineering President Tsu-Jae Liu. “This report highlights the importance of workforce development for achieving and maintaining a competitive edge in advanced manufacturing, for economic prosperity and national security. 

Manufacturing USA institutes should adopt a broad range of programs to address workforce education needs that are built around a unified advanced manufacturing curriculum, the report says. In collaboration with regional stakeholders, this should include broad support for manufacturing apprenticeships and the development of comprehensive online advanced manufacturing courses.

The report also calls for a new interagency council to enable cross-agency and cross-institute collaboration, reduce administrative barriers, develop a digital manufacturing strategy, and establish an integrated strategy for the manufacturing institutes. Cross-agency collaboration is important between institute sponsoring agencies as well as between the institutes and other federal programs, including the national laboratories and the Manufacturing Extension Partnership program, to ensure advanced manufacturing technologies developed by the institutes are disseminated widely. Federal funding on par with comparable effective programs abroad is critical for supporting these activities.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, engineering, and medicine. They operate under an 1863 congressional charter to the National Academy of Sciences, signed by President Lincoln.

For more information, visit https://www.nationalacademies.org/.

Source link

Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform

ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”) (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing for critical care, today announced a strategic partnership with Argonaut Manufacturing Services (“Argonaut”) to support the advancement of Bluejay’s Symphony™ platform.

This partnership is designed to support Bluejay’s broader efforts to establish scalable U.S.-based manufacturing capabilities aligned with its ongoing clinical development programs and future commercialization objectives. In addition, the partnership is intended to strengthen Bluejay’s future commercial infrastructure by supporting broader product distribution across the United States, enhancing supply chain resilience, and reducing potential risks associated with international sourcing and import tariffs. The collaboration is also intended to mitigate risks associated with Bluejay’s current reliance on overseas manufacturing by establishing domestic manufacturing capabilities that can provide greater operational control, business continuity, and supply chain security. By leveraging U.S.-based manufacturing and distribution capabilities, Bluejay aims to improve operational flexibility, support future market demand, and further enhance its ability to commercialize innovative near-patient diagnostic solutions for critical care settings.

“We are pleased to partner with Argonaut as we continue to advance the Symphony™ platform,” said Neil Dey, President and Chief Executive Officer of Bluejay Diagnostics. “This collaboration reflects our commitment to building a scalable and quality-focused operational foundation as we progress toward key commercial milestones.”

“Argonaut is committed to partnering with innovative companies to support the advancement of differentiated diagnostic technologies,” said Rick Hancock, Chief Executive Officer of Argonaut Manufacturing Services. “We value this collaboration with Bluejay Diagnostics and look forward to supporting their efforts as they continue to develop solutions aimed at improving clinical decision-making in critical care settings.”

Note: Investigational device. Limited by United States law to investigational use.

About the SYMON Clinical Study Program:

The SYMON Clinical Study Program includes SYMON-I (clinicaltrials.gov ID NCT06181604), SYMON-II (NCT06654895), and SYMON-III (NCT07425587). SYMON-I is a pilot study to determine IL-6 levels associated with various endpoints, including, but not limited to 28-day all-cause mortality and in-hospital mortality. The SYMON-II study is the pivotal study to validate the outcomes of the SYMON-I study, which the Company plans to use to support a 510(k) application to the FDA. The SYMON-III study is a pilot study to determine IL-6 levels associated with patients presenting with increasing severity of infection in the emergency department and risk of developing sepsis.

About Bluejay Diagnostics:

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay does not yet have regulatory clearance for the Symphony System, and we will need to receive regulatory authorization from the U.S. Food and Drug Administration before Symphony can be marketed as a diagnostic product in the United States. Bluejay’s first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from ’sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions. More information is available at www.bluejaydx.com.

About Argonaut Manufacturing Services:

Argonaut Manufacturing Services

is a contract manufacturing organization focused on supporting life sciences and diagnostics companies with high-quality manufacturing solutions. Founded by former executives from companies such as Thermo Fisher Scientific, Affymetrix, and Allergan, Argonaut was built to provide a better, customer-focused approach to contract manufacturing.

The company’s mission is centered on improving the human condition by helping partners bring innovative healthcare products to market efficiently and reliably. Drawing from decades of industry experience, Argonaut emphasizes quality, operational excellence, and strong customer collaboration to help clients achieve their commercial and development goals in the health and life sciences industries.

Forward-Looking Statements:

This press release contains statements that the Company believes are “forward-looking statements” within the meaning of the Private Litigation Reform Act. Forward-looking statements may be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “suggest,” “will,” and similar expressions. The Company has based these forward-looking statements on its current expectations and projections about future events, nevertheless, actual results or events could differ materially from the plans, intentions and expectations disclosed in, or implied by, the forward-looking statements the Company makes. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including market and other conditions and those discussed under item 1A. “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in Part II, Item 1A, “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. You should not place undue reliance on these forward-looking statements, as they are subject to risks and uncertainties, and actual results and performance in future periods may not occur or may be materially different from any future results or performance suggested by the forward-looking statements in this release. This press release speaks as of the date indicated above. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any future changes in the Company’s expectations of results or any future change in events, except as required by law.

Investor Contact:


Neil Dey

Bluejay Diagnostics, Inc.


[email protected]

Website: www.bluejaydx.com

Source link

US Dollar gains ground after strong Manufacturing data as US-Iran tensions persist

Here is what you need to know for Tuesday, June 2:

The US Dollar Index (DXY) rises toward the 99.20 region on Monday after stronger-than-expected US manufacturing data reinforced confidence in the resilience of the United States (US) economy.

The ISM Manufacturing PMI rose to 54 in May from 52.7, beating expectations of 53, while the Employment Index improved to 48.6. Meanwhile, investors continued monitoring developments in the Middle East after Iran halted message exchanges with the United States, although sentiment improved later after President Donald Trump stated that there would be no troops sent to Beirut and that Hezbollah had agreed to stop all shooting.

US Dollar Price Today

The table below shows the percentage change of US Dollar (USD) against listed major currencies today. US Dollar was the strongest against the New Zealand Dollar.

USDEURGBPJPYCADAUDNZDCHFUSD0.22%-0.06%0.27%0.28%0.29%0.88%0.71%EUR-0.22%-0.27%0.00%0.07%0.13%0.68%0.48%GBP0.06%0.27%0.30%0.34%0.32%0.90%0.74%JPY-0.27%0.00%-0.30%0.04%0.05%0.65%0.45%CAD-0.28%-0.07%-0.34%-0.04%0.00%0.59%0.41%AUD-0.29%-0.13%-0.32%-0.05%0.00%0.53%0.39%NZD-0.88%-0.68%-0.90%-0.65%-0.59%-0.53%-0.18%CHF-0.71%-0.48%-0.74%-0.45%-0.41%-0.39%0.18%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

EUR/USD stumbles near the 1.1630 area, pressured by broad US Dollar strength following the upbeat ISM report. The pair struggles to gain traction as markets focus on resilient US economic data.

GBP/USD trades muted near 1.3460 as the Greenback weakens after its early rally. The pair remains under pressure despite relatively stable risk sentiment.

USD/JPY advances toward the 159.70 zone as higher US yields and stronger US economic data support the pair. The pair is close to intervention levels, so investors will watch any Japanese reaction when the Asian session opens.

AUD/USD declines toward the 0.7160 region as the stronger US Dollar and cautious market sentiment weigh on the Australian Dollar (AUD).

West Texas Intermediate (WTI) Oil trades near $92.40 per barrel after volatile headlines surrounding the Middle East. Prices initially found support after Iran suspended message exchanges with the US, but gains were limited after Trump stated he was not worried about Oil prices even if Iran were to block the Strait of Hormuz and indicated that tensions in Lebanon may ease.

Gold (XAU/USD) fell near the $4,480 region, even amid geopolitical uncertainty, as markets choose to back the stronger US Dollar and rising Treasury yields following the upbeat ISM Manufacturing report.

What’s next in the docket:

Tuesday, June 2:

• Eurozone CPI
• US JOLTS Job Openings
• NZ Building Permits
• AU AiG Industry Index
• AU PMI
• AU Q1 GDP
• China Caixin Services PMI

Wednesday, June 3:

• Spain Services PMI
• Germany PMI
• Eurozone PMI
• Eurozone PPI
• US ADP Employment Change 4-week average
• US PMI
• US Factory Orders
• AU Trade Balance

Thursday, June 4:

• CH CPI
• Eurozone Retail Sales
• US Challenger Job Cuts
• US Initial Jobless Claims
• US Nonfarm Productivity
• US Unit Labor Costs
• JP Labor Cash Earnings

Friday, June 5:

• Eurozone GDP
• Eurozone Employment Change
• CA Employment Report
• CA Average Hourly Wages
• CA Unemployment Rate
• US Nonfarm Payrolls
• US Unemployment Rate
• US Average Hourly Earnings
• US Labor Force Participation Rate
• CA Ivey PMI

WTI Oil FAQs

WTI Oil is a type of Crude Oil sold on international markets. The WTI stands for West Texas Intermediate, one of three major types including Brent and Dubai Crude. WTI is also referred to as “light” and “sweet” because of its relatively low gravity and sulfur content respectively. It is considered a high quality Oil that is easily refined. It is sourced in the United States and distributed via the Cushing hub, which is considered “The Pipeline Crossroads of the World”. It is a benchmark for the Oil market and WTI price is frequently quoted in the media.

Like all assets, supply and demand are the key drivers of WTI Oil price. As such, global growth can be a driver of increased demand and vice versa for weak global growth. Political instability, wars, and sanctions can disrupt supply and impact prices. The decisions of OPEC, a group of major Oil-producing countries, is another key driver of price. The value of the US Dollar influences the price of WTI Crude Oil, since Oil is predominantly traded in US Dollars, thus a weaker US Dollar can make Oil more affordable and vice versa.

The weekly Oil inventory reports published by the American Petroleum Institute (API) and the Energy Information Agency (EIA) impact the price of WTI Oil. Changes in inventories reflect fluctuating supply and demand. If the data shows a drop in inventories it can indicate increased demand, pushing up Oil price. Higher inventories can reflect increased supply, pushing down prices. API’s report is published every Tuesday and EIA’s the day after. Their results are usually similar, falling within 1% of each other 75% of the time. The EIA data is considered more reliable, since it is a government agency.

OPEC (Organization of the Petroleum Exporting Countries) is a group of 12 Oil-producing nations who collectively decide production quotas for member countries at twice-yearly meetings. Their decisions often impact WTI Oil prices. When OPEC decides to lower quotas, it can tighten supply, pushing up Oil prices. When OPEC increases production, it has the opposite effect. OPEC+ refers to an expanded group that includes ten extra non-OPEC members, the most notable of which is Russia.

Source link